Read the full article here.
This content was originally published by IoL Business Report. Original publishers retain all rights. It appears here for a limited time before automated archiving. By IoL Business Report
The drugmaker sees no immediate impact of India’s decision this week to restrict the export of 26 pharmaceutical ingredients due to coronavirus.